Transcranial low‐frequency pulsating electromagnetic fields (T‐PEMF) as post‐concussion syndrome treatment

Background Treatment options for the subgroup of people who develop long‐lasting symptoms following mild traumatic brain injury are limited. Transcranial pulsating low‐frequency electromagnetic stimulation (T‐PEMF) in other patient groups has shown promising results in several studies with proposed...

Full description

Saved in:
Bibliographic Details
Published inActa neurologica Scandinavica Vol. 142; no. 6; pp. 597 - 604
Main Authors Miller, Claire Prener, Prener, Martin, Dissing, Steen, Paulson, Olaf B.
Format Journal Article
LanguageEnglish
Published Denmark John Wiley & Sons, Inc 01.12.2020
John Wiley and Sons Inc
Subjects
Adult
Concussion
Electromagnetic fields
electromagnetic stimulation
Female
Humans
Inflammation
Male
mTBI
Neuroprotection
Original
PCS
Pilot Projects
Post-Concussion Syndrome - therapy
post‐concussion syndrome
Transcranial Magnetic Stimulation - adverse effects
Transcranial Magnetic Stimulation - methods
Traumatic brain injury
T‐PEMF
PCS
T-PEMF
concussion
electromagnetic stimulation
mTBI
post-concussion syndrome
Online AccessGet full text

Cover

More Information
Summary:Background Treatment options for the subgroup of people who develop long‐lasting symptoms following mild traumatic brain injury are limited. Transcranial pulsating low‐frequency electromagnetic stimulation (T‐PEMF) in other patient groups has shown promising results in several studies with proposed neuroprotective and anti‐inflammatory effects. Objective The present pilot study was conducted to access feasibility and tolerability of T‐PEMF in treating post‐concussion syndrome. Methods Seven patients with post‐concussion syndrome received 5 weeks of daily 30 minutes T‐PEMF treatment with evaluation after 2 and 5 weeks and 3 months after ending treatment. Results Compliance was high as all subject completed the full treatment. Two patients however experienced a worsening of their concussion symptoms during the course of treatment. The remaining patients had some discomfort in relation to treatment, mainly headache, but passing and less for each treatment. The majority (n = 5) had a reduction in symptoms overall, up to 61% (2%‐61%) based on the Rivermead Post‐Concussion Symptoms Questionnaire. Conclusion Further studies on T‐PEMF as a treatment option for post‐concussion syndrome are warranted.
Bibliography:Funding information
This work was supported with a grant from Hørslev Fonden.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:0001-6314
1600-0404
1600-0404
DOI:10.1111/ane.13300